International Biotechnology

Technology

Gaining exposure to biotech in times of uncertainty

Omicron variant saw wild price jumps

13 December 2021 • 4 min read

Investment Trusts

The race for a vaccine: The investment trust managers combating coronavirus

Outlooks for the biotech sector

07 April 2020 • 6 min read

Specialist

Why the long-term outlook for biotech sector remains intact

The healthcare sector has been under a black cloud since the US Presidential Election last year, driven by concerns over drug pricing.

16 August 2017 • 2 min read

Specialist

Biotech: Forget 'Trumpcare', M&A will be biggest driver

Large acquisitions due

22 March 2017 • 2 min read

US

Why investors need not be concerned by Hillary's plans to clamp down on drug pricing

Concerns have been mounting in the run-up to the US election, particularly over Hillary Clinton's proposed clamp down on drug pricing, writes Carl Harald Janson.

04 November 2016 • 2 min read

Investment Trusts

International Biotechnology trust to introduce 4% annual dividend

Subject to shareholder approval

12 September 2016 • 3 min read

Investment Trusts

Biotech and commodity trusts top performance tables in July

Latest roundup by QuotedData

09 August 2016 • 2 min read

Specialist

Why smaller companies are the answer to benefitting from biotech industry changes

Overuse of antibiotics around the globe has created a worrying increase in resistance to many commonly used drugs, writes Carl Harald Janson, lead manager on the International Biotechnology trust.

18 July 2016 • 2 min read